Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Euro RSCG has landed advertising duties on osteoporosis drug Boniva after a review in which the incumbent, Saatchi & Saatchi Consumer Healthcare, did not participate, sources said.
The Havas-owned agency’s New York office trumped Omnicom Group’s BBDO, also New York, in the final round, according to sources.
Boniva, jointly marketed by GlaxoSmithKline and Roche, had a 2005 U.S. media spend of $70 million, per Nielsen Monitor-Plus. From January through July of this year, the companies spent $75 million in U.S.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in